Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03043586 · ClinicalTrials.gov registry record
Treatment Patterns and Treatment Outcomes for Acromegaly
A clinical trial of Acromegaly, sponsored by Columbia University.
- Completed
- Registry status
- 520
- Enrollment target
- 1
- Study location
NCT03043586: Completed study of Acromegaly, sponsored by Columbia University.
NCT03043586 is a study of Acromegaly that has completed, run by Columbia University. The registered enrollment target is 520 participants, above the 61-participant average among 13 other Acromegaly trials with a reported enrollment target (752% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03043586, a study of Acromegaly, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 520 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a human, prospective and retrospective, single-center study of patients who have undergone treatment for acromegaly in New York City since 1981. The project will characterize, among other factors, the treatment methods received by patients, who administered the treatments and the success of this therapy in terms of biochemical control.
Primary Outcome
Frequency of each type of acromegaly therapy and rates of treatment by surgery alone, somatostatin analog, pegvisomant, radiotherapy and combinations of each of these therapies in the cohort will be recorded and determined. The expected result is that more than 90% of our cohort has received surgery as first line therapy and only a minority has received primary medical therapy.
Conditions Studied
Study Locations (1)
New York
- Neuroendocrine Unit at Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520 participants |
| Start Date | 2016-12 |
| Est. Completion | 2025-04-30 |
What the finished NCT03043586 record still lists
NCT03043586 is an observational study that tracks outcomes without assigning an intervention. The registered 520 participants enrollment target is mid-sized for trials with a published cap, above the 61-participant average among 13 other Acromegaly trials with a reported enrollment target (752% higher).
The record links to 1 condition, with Acromegaly appearing as the primary indexed condition, and to 0 interventions.
NCT03043586 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03043586 about?
NCT03043586 is a clinical study titled "Treatment Patterns and Treatment Outcomes for Acromegaly". This is a human, prospective and retrospective, single-center study of patients who have undergone treatment for acromegaly in New York City since 1981. The project will characterize, among other factors, the treatment methods received by patients, who administered the treatments and the success of ...
What is the current status of trial NCT03043586?
This trial is currently completed. The enrollment target is 520 participants. The study started on 2016-12. Estimated completion is 2025-04-30.
What conditions does trial NCT03043586 study?
This clinical trial studies the following conditions: Acromegaly.
Who is sponsoring clinical trial NCT03043586?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03043586 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acromegaly
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03043586's enrollment target sits among peer trials
520 1st of 13 higher than 13 of 13 other Acromegaly trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acromegaly trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
RECRUITING · Phase 3
-
Diet in the Management of Acromegaly
RECRUITING · NA
-
Study of MAR002 in Healthy Men
RECRUITING · Phase 1
-
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
ACTIVE NOT RECRUITING
-
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
- NCT04656496 · 520 participants · NA
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
- NCT05445778 · 520 participants · Phase 3
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- NCT05498428 · 520 participants · Phase 2
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia